TPA
ABBV icon

Trivium Point Advisory’s AbbVie ABBV Stock Holding History

Trivium Point Advisory’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.7M Buy
10,728
+5,641
+111% +$1.21M 0.24% 98
2026
Q1 		$1.11M Sell
5,087
-5,227
-51% -$1.16M 0.2% 123
2025
Q4 		$2.36M Sell
10,314
-53
-0.5% -$12.1K 0.24% 104
2025
Q3 		$2.4M Sell
10,367
-86
-0.8% -$17.5K 0.25% 103
2025
Q2 		$1.94M Buy
10,453
+899
+9% +$167K 0.21% 120
2025
Q1 		$2M Buy
9,554
+341
+4% +$66.3K 0.25% 112
2024
Q4 		$1.64M Sell
9,213
-20
-0.2% -$3.68K 0.21% 123
2024
Q3 		$1.57M Sell
9,233
-1,772
-16% -$331K 0.22% 123
2024
Q2 		$1.89M Buy
11,005
+4,317
+65% +$715K 0.28% 104
2024
Q1 		$1.22M Sell
6,688
-129
-2% -$22.2K 0.26% 100
2023
Q4 		$1.06M Buy
6,817
+120
+2% +$17.5K 0.26% 105
2023
Q3 		$987K Buy
6,697
+443
+7% +$65K 0.27% 109
2023
Q2 		$843K Buy
6,254
+112
+2% +$16.4K 0.23% 122
2023
Q1 		$979K Buy
6,142
+4,363
+245% +$667K 0.26% 118
2022
Q4 		$296K Sell
1,779
-2
-0.1% -$307 0.09% 158
2022
Q3 		$250K Sell
1,781
-224
-11% -$32.1K 0.08% 163
2022
Q2 		$305K Sell
2,005
-1,842
-48% -$281K 0.09% 166
2022
Q1 		$650K Buy
3,847
+503
+15% +$73.1K 0.14% 152
2021
Q4 		$453K Buy
3,344
+499
+18% +$58.9K 0.1% 172
2021
Q3 		$315K Buy
2,845
+109
+4% +$12.5K 0.07% 180
2021
Q2 		$308K Buy
+2,736
New +$308K 0.08% 182

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Trivium Point Advisory's ABBV Position: Q2 2026 in Review

Trivium Point Advisory increased its AbbVie (ABBV) stake by 111% in Q2 2026, buying an estimated $1.21M and bringing the position to 10,728 shares worth $2.7M. The position accounts for 0.24% of the portfolio, ranked #98.

Trivium Point Advisory first reported a position in ABBV in Q2 2021 and has held it in 21 quarters since. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Trivium Point Advisory held 10,728 shares of AbbVie worth $2.7M as of Q2 2026.
  • Trivium Point Advisory bought 5,641 AbbVie shares in Q2 2026, an estimated $1.21M.
  • AbbVie made up 0.24% of Trivium Point Advisory's portfolio in Q2 2026, its #98 holding.
  • Trivium Point Advisory first reported a position in AbbVie in Q2 2021 and has held it in 21 quarters since.
  • 4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Trivium Point Advisory's 13F filing for Q2 2026, filed 6 Aug 2026.